Holen Sie sich die Stockscreener-App
26.96
8.27%
2.06
Handel nachbörslich:
26.96
Staar Surgical Co Aktie (STAA) Neueste Nachrichten
Staar Surgical adjourns vote on acquisition by Alcon - Reuters
Alcon and STAAR Surgical adjourn special stockholder meeting - Investing.com India
Alcon and STAAR Surgical adjourn special stockholder meeting By Investing.com - Investing.com South Africa
Hold Rating on Staar Surgical Amid Uncertainty from Postponed Shareholder Vote and Updated Financial Projections - TipRanks
Staar Surgical Postpones Shareholder Vote on Alcon Merger - Orange County Business Journal
STAAR Surgical (STAA) Faces Shareholder Pushback on Alcon Acquis - GuruFocus
Can STAAR Surgical Company stock resist market sell offs2025 Trading Volume Trends & Precise Trade Entry Recommendations - newser.com
Staar Surgical's top investor calls shareholder meeting to remove directors - Reuters
Broadwood moves to oust STAAR Surgical directors over Alcon deal By Investing.com - Investing.com South Africa
Broadwood Calls for Removal of Several Staar Directors - Orange County Business Journal
Staar Surgical Faces Investor Revolt Over $1.5 Billion Takeover - Finimize
Global Cataract Surgery Devices Market to Grow at a CAGR of - GlobeNewswire
STAAR Surgical Q3 2025 preliminary net sales up 6.9% to USD 94.7M - Medical Buyer
STAAR Surgical reports preliminary Q3 net sales up 6.9% to $94.7 million - Investing.com Nigeria
Yunqi Capital Issues Letter to Board of Directors of Staar Opposing Alcon Acquisition - MarketScreener
Yunqi Capital reiterates opposition to STAAR Surgical-Alcon merger - Investing.com
Yunqi Capital reiterates opposition to STAAR Surgical-Alcon merger By Investing.com - Investing.com Canada
Yunqi Capital issues letter to Staar Surgical's board calling for timely convening of special meeting to vote on Alcon transaction - MarketScreener
Yunqi Capital Issues Letter to STAAR Surgical’s Board Calling for Timely Convening of the Special Meeting to Vote on the Alcon Transaction - MarketScreener
STAAR Surgical earnings missed by $0.02, revenue topped estimates - Investing.com
Proxy firms and shareholders oppose STAAR Surgical acquisition by Alcon - Investing.com
STAAR Surgical rises premarket after Q3 prelim sales beat - TradingView
STAAR Surgical Topped Estimates, But Analysts Still Hold Back - Finimize
Broadwood Partners Highlights Growing Opposition to STAAR Surgical’s Proposed Sale to Alcon - MarketScreener
Broadwood Partners Provides Information to Shareholders of STAAR Surgical - MarketScreener
STAA Reports Growth in Net Sales Fueled by December Shipment - GuruFocus
STAAR Surgical (STAA) Releases Q3 Sales Data Exceeding Expectati - GuruFocus
STAAR Surgical prelim Q3 sales beat estimates, boosted by deferred China shipment - MarketScreener
STAAR Surgical Announces Preliminary Net Sales Results for Third Quarter 2025 - MarketScreener
$94.7M preliminary Q3 net sales — STAAR Surgical recognized $25.9M from Dec. China shipment; vote Oct. 23 - Stock Titan
What data driven models say about STAAR Surgical Company’s futureWeekly Trend Recap & AI Driven Stock Movement Reports - newser.com
STAAR Surgical says no other acqusition proposals other than Alcon - MSN
Broadwood urges STAAR board to proceed with acquisition vote By Investing.com - Investing.com Nigeria
Broadwood urges STAAR board to proceed with acquisition vote - Investing.com
27.5% owner Broadwood urges STAAR Surgical shareholders to vote "AGAINST" Alcon sale; vote Oct 23, 2025 - Stock Titan
STAAR Surgical Company (STAA) Stock Analysis: Navigating Growth Challenges and Investment Potential - DirectorsTalk Interviews
ISS recommendation may toll the bell for STAAR–Alcon deal, validates Broadwood - Investing.com
STAAR Surgical (STAA): A Fresh Look at Valuation After Recent Share Price Pullback - simplywall.st
STAAR Surgical (STAA) Urges Stockholders to Support Alcon Merger - GuruFocus
Staar Surgical says no acquisition proposals received except from Alcon - TipRanks
STAAR disputes Broadwood’s claims about acquisition offers - Investing.com India
STAAR disputes Broadwood’s claims about acquisition offers By Investing.com - Investing.com Nigeria
Independent Poxy Advisory Firms Issues Recommendations to Shareholders of Broadwood Partners - MarketScreener
Midday Stock Roundup: Eledon up 16% on Kidney Presentation - Orange County Business Journal
Staar sale to Alcon eclipsed by shareholder, proxy advisor concerns - BioWorld MedTech
Broadwood Partners All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote AGAINST Sale to Alcon - MarketScreener
ISS recommends Staar shareholders reject Alcon's $1.5 billion offer - Reuters
Alcon's (ALC) Proposed Acquisition Faces Major Opposition - GuruFocus
ISS Recommends Staar Shareholders Vote Against Alcon Merger - Orange County Business Journal
Broadwood: Proxy advisory firms recommend Staar shareholders vote against sale - TipRanks
Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “AGAINST” Sale to Alcon - MarketScreener
Oklahoma City NewsThe Oklahoman - FinancialContent
STAAR Surgical (STAA) Shareholders Advised to Reject Alcon's Acq - GuruFocus
Broadwood urges “AGAINST” vote on Alcon deal as advisors dissent - Stock Titan
Broadwood Partners Comments on STAAR Surgical’s Late and Troubling Disclosure in Deeply Flawed Sale Process to Alcon - Stock Titan
STAAR Surgical Announces Merger with Alcon Amid Legal Challenges - TradingView
Where Does STAAR Surgical Stand After EVO+ Launch and Recent Share Price Swings? - Yahoo
Large Staar Holders Oppose $1.5B Sale - Orange County Business Journal
Broadwood slams STAAR board over “carelessness” in Alcon sale defense By Investing.com - Investing.com Canada
Broadwood slams STAAR board over “carelessness” in Alcon sale defense - Investing.com
1.98%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):